March 8, 2018 – Children often find it difficult to remain still for magnetic resonance imaging (MRI) examinations, but an alternative method to conventional MRI for pediatric patients has shown promise in reducing motion-related artifacts in brain imaging, according to an article published online ahead of print from the April 2018 issue of the 

March 8, 2018 – Vital Images announced that its enterprise analytics solution, Vitrea Intelligence, will be deployed at Imaging Queensland, a premier imaging network in Australia. Deployment is scheduled for the second quarter of 2018. Vitrea Intelligence comprises Opportunity Navigator predictive analytics and Practice Management business intelligence.

March 8, 2018 –   Fujifilm Medical Systems U.S.A. Inc., a provider of diagnostic imaging products with a comprehensive portfolio of women’s health solutions, will unveil its latest mammography diagnostic workstation, the Aspire Bellus II, at the National Consortium of Breast Centers (NCoBC) conference, March 9 -14, 2018, in Las Vegas and the Society of

March 8, 2018 – The current guidelines for mammographic breast cancer screening, which are based on data from primarily white populations, may lead to delayed diagnosis in nonwhite women, according to a report published in JAMA Surgery.

March 8, 2018 – Doctors contemplating the best therapy for lung cancer patients may soon be able to predict the efficacy of a widely used lung cancer drug based on an imaging agent and a simple scan, according to the findings of a new clinical trial co-led by researchers at the Stanford University School of Medicine.

As we get older, it's not uncommon to experience "senior moments," in which we forget where we parked our car or call our children by the wrong names. But currently there are no good ways to determine which memory lapses are normal parts of aging and which may signal the early stages of a severe disorder like Alzheimer's disease. In a study appearing March 7 in the journal Neuron, researchers report that data from high-resolution functional brain imaging can be used to show some of the underlying causes for differences in memory proficiency between older and younger adults.

An Italian study featured in the March issue of The Journal of Nuclear Medicine demonstrates that a novel nuclear medicine imaging agent targeting copper accumulation in tumors can detect prostate cancer recurrence early in patients with biochemical relapse (rising prostate-specific antigen [PSA] level).

Turning 40 is a benchmark birthday for many women in the United States. While a pessimist might view it as a signal that their glory days are over, more and more women are optimistic about the milestone, seeing it as a kickoff into the best years of their lives. But one thing is true for all women – health needs and preventative wellness routines should begin to change at age 40.

OptiStar Elite injector

The global contrast media injectors market is expected to reach $1.4 billion by 2025, growing at a compound annual growth rate (CAGR) of 5.8 percent, according to a new report by Grand View Research, Inc., a research firm based in San Francisco. Rising demand for minimally invasive surgical procedures is a major factor expected to boost the market during the forecast period. These devices assist surgeons in accurate insertion of contrast agents with reduced human errors, thus increasing the accuracy and efficiency of surgical procedures. They play a crucial role in intra-operative computed tomography (iCT), intra-operative magnetic resonance imaging (iMRI) and interventional cardiology. Availability of advanced injector systems for diagnosis and intra-operative imaging has boosted adoption of these systems.
Fujifilm introduced a DBT option to the Aspire Cristalle full-field digital mammography (FFDM) system in 2017 following FDA approval for the upgrade.

In the world of breast imaging, digital breast tomosynthesis (DBT) is a relative newcomer, only being adopted into clinical practice in the last 8 years. The benefits of DBT, also known as 3-D mammography, are generally understood — improved cancer detection over traditional 2-D mammography due to the ability to scroll through different slices of the breast to see lesions undetectable in two dimensions. While the evidence for DBT has been mounting, new data reveal the technology has seen explosive growth in the last 18 months.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now